Affimed (AFMD) Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types : vimarsana.com

Affimed (AFMD) Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types

Affimed (AFMD) Presents Preclinical Data Showing that Addition of an Innate Cell Engager to NK and CAR-NK Cells Improves Tumor Cytotoxicity of Both Cell Types

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , Stephan Fricke , Joachim Koch , Michael Albers , Jens Pahl , Christoph Bach , Thea Eichenberg , Julia Uhlig , Christian Breunig , Sonya Ioana Ciulean , Arndt Schottelius , Paul Franz , Joe Fischer , Ivica Fucek , Jan Schmollinger , Thomas Grunwald , Society For Immunotherapy Of Cancer , San Diego Convention Center , Fraunhofer Institute For Cell Therapy , Fraunhofer Institute , Cell Therapy , Chief Scientific Officer , Innate Cell Engagers , Presentation Time , Exhibit Halls , San Diego Convention ,